Morepen Laboratories Limited (NSE:MOREPENLAB)
120.08
-2.27 (-1.86%)
Sep 24, 2026, 11:10 AM IST
Morepen Laboratories Revenue
Morepen Laboratories had revenue of 5.70B INR in the quarter ending June 30, 2026, with 34.07% growth. This brings the company's revenue in the last twelve months to 19.51B, up 9.48% year-over-year. In the fiscal year ending March 31, 2026, Morepen Laboratories had annual revenue of 18.06B, down -0.32%.
Revenue (ttm)
19.51B
Revenue Growth
+9.48%
P/S Ratio
3.44
Revenue / Employee
10.16M
Employees
1,919
Market Cap
67.04B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.06B | -58.84M | -0.32% |
| Mar 31, 2025 | 18.12B | 1.21B | 7.17% |
| Mar 31, 2024 | 16.90B | 2.68B | 18.88% |
| Mar 31, 2023 | 14.22B | -1.34B | -8.60% |
| Mar 31, 2022 | 15.56B | 3.58B | 29.87% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 50.04B |
| Akums Drugs and Pharmaceuticals | 45.04B |
| NATCO Pharma | 34.85B |
| Aarti Pharmalabs | 19.69B |
| Sun Pharma Advanced Research Company | 19.09B |
| Innova Captab | 17.49B |
| Solara Active Pharma Sciences | 14.31B |
| Orchid Pharma | 8.52B |
Morepen Laboratories News
- 2 months ago - Morepen Laboratories announces resignation of senior management personnel Bhola Prasad - Business Upturn
- 2 months ago - Morepen Laboratories shares surge over 4% as company begins commercial supplies under Rs 825 crore CDMO Mandate - Business Upturn
- 2 months ago - Morepen Laboratories completes first ₹50 crore dispatch under ₹825 crore CDMO mandate - Business Upturn
- 3 months ago - Morepen Laboratories shares rally sharply over 13% today: Details here - Business Upturn
- 4 months ago - Why are Morepen Lab shares falling sharply over 5% today? Explained - Business Upturn
- 4 months ago - Morepen Labs Q4 net profit surges 69% as CDMO programme enters commercial phase - Business Upturn
- 4 months ago - Morepen Laboratories appoints Vipul Kumar Srivastava as Company Secretary - Business Upturn
- 5 months ago - Morepen Laboratories secures Rs 30 crore term loan from Shinhan Bank - Business Upturn